NURECA
Quarterly Results Analysis [Dec2023]
NURECA Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹22 Cr | ₹31 Cr | ₹21 Cr | ₹21 Cr | ₹28 Cr | ₹37 Cr | ₹26 Cr | ₹41 Cr |
Expenses | ₹27 Cr | ₹30 Cr | ₹24 Cr | ₹25 Cr | ₹29 Cr | ₹42 Cr | ₹31 Cr | ₹44 Cr |
Operating Income | ₹-4 Cr | ₹1 Cr | ₹-3 Cr | ₹-3 Cr | ₹-1 Cr | ₹-5 Cr | ₹-6 Cr | ₹-3 Cr |
Other Income | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹1 Cr | ₹4 Cr | ₹-1 Cr | ₹-2 Cr | ₹0 Cr | ₹-4 Cr | ₹-5 Cr | ₹-2 Cr |
Profit After Tax | ₹0 Cr | ₹3 Cr | ₹-1 Cr | ₹-2 Cr | ₹0 Cr | ₹-3 Cr | ₹-4 Cr | ₹-1 Cr |
EPS | ₹0.17 | ₹2.89 | ₹-0.71 | ₹-1.53 | ₹0.30 | ₹-2.89 | ₹-4.13 | ₹-1.40 |
Industry Peers & Returns | 1W | 1M | 1Y |
NURECA | -5.6% | -18.7% | -6.7% |
POLY MEDICURE | 5.1% | -3.2% | 67.7% |
PREVEST DENPRO | -0.7% | -13.2% | 24.9% |
NURECA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -28.64 % |
Y-o-Y | -19.48 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹22 Cr | -28.64 | |
Sep2023 | ₹31 Cr | 47.68 | |
Jun2023 | ₹21 Cr | 0.02 | |
Mar2023 | ₹21 Cr | -23.61 | |
Dec2022 | ₹28 Cr | -24.45 | |
Sep2022 | ₹37 Cr | 44.08 | |
Jun2022 | ₹26 Cr | -37.81 | |
Mar2022 | ₹41 Cr | - |
NURECA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹-4 Cr | Negative | |
Sep2023 | ₹1 Cr | Positive | |
Jun2023 | ₹-3 Cr | Negative | |
Mar2023 | ₹-3 Cr | Negative | |
Dec2022 | ₹-1 Cr | Negative | |
Sep2022 | ₹-5 Cr | Negative | |
Jun2022 | ₹-6 Cr | Negative | |
Mar2022 | ₹-3 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | -19.02% | Negative | |
Sep2023 | 4.42% | Positive | |
Jun2023 | -13.67% | Negative | |
Mar2023 | -16.28% | Negative | |
Dec2022 | -3.3% | Negative | |
Sep2022 | -13.34% | Negative | |
Jun2022 | -22.44% | Negative | |
Mar2022 | -6.67% | - |
NURECA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -94.30 % |
Y-o-Y | -45.18 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹0 Cr | -94.30 | |
Sep2023 | ₹3 Cr | Positive | |
Jun2023 | ₹-1 Cr | Negative | |
Mar2023 | ₹-2 Cr | Negative | |
Dec2022 | ₹0 Cr | Positive | |
Sep2022 | ₹-3 Cr | Negative | |
Jun2022 | ₹-4 Cr | Negative | |
Mar2022 | ₹-1 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -91.98 % |
Y-o-Y | -31.48 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 0.74 % | -91.98 | |
Sep2023 | 9.23 % | Positive | |
Jun2023 | -3.33 % | Negative | |
Mar2023 | -7.21 % | Negative | |
Dec2022 | 1.08 % | Positive | |
Sep2022 | -7.86 % | Negative | |
Jun2022 | -16.17 % | Negative | |
Mar2022 | -3.42 % | - |
NURECA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -94.12 % |
Y-o-Y | -43.33 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.17 | -94.12 | |
Sep2023 | ₹2.89 | Positive | |
Jun2023 | ₹-0.71 | Negative | |
Mar2023 | ₹-1.53 | Negative | |
Dec2022 | ₹0.3 | Positive | |
Sep2022 | ₹-2.89 | Negative | |
Jun2022 | ₹-4.13 | Negative | |
Mar2022 | ₹-1.4 | - |
You may also like the below Video Courses
Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of PREVEST DENPRO LTD Intrinsic Value of NURECA LTD |